In the current era of acute coronary interventions, patients who suffer a myocardial infarction (MI) are discharged either to home or to a rehabilitation facility very rapidly, after just a few days. Mortality, however, is highest during the first month after MI. Patients with decreased left ventricular systolic function who lost a significant percentage of their myocardium are at the highest risk. Given the advances of telemedicine, it may therefore be important to develop new methods of home arrhythmia monitoring for these patients.
To determine the reliability of an internet-based continuous home arrhythmia monitoring during the first month after discharge in patients with decreased left ventricular function who suffered an acute MI and underwent coronary intervention.
Numerous telephone-based ECG monitoring systems exist but the authors present their experiences with a new technology involving continuous internet-based ECG monitoring which does not require activation by the patient. A mobile internet-based device was developed for patients who had no access to internet.
We monitored 10 post-MI patients with an ejection fraction of less than 40% who were discharged home. Cumulative monitoring time was 170 days. The completely noise-free and error-free ECG periods amounted to 98 % and 99%, respectively. Average time to response to the 66 alarms raised was 27 seconds. The average number of alarms per day was 0.39 while the positive predictive value was 0.106. Total alarm time was 29.8 minutes which works out to 10.5 seconds per day.
As the unique chest band we developed makes it possible to record error-free ECGs during most of the monitoring period, our method appears to be suitable for home monitoring of patients discharged from hospital. The low alarm time means that many patients can be monitored simultaneously without compromising patient safety.
[1]. E. Kékes I. Édes 2007 The value of the transtelephonic ECG system in the clinical praxis of cardiology Orv. Hetil. 148 1443–1449.
[2]. S. D. Solomon S. Zelenkofske J. J. McMurray et al.2005 Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N. Engl. J. Med. 352 2581–2588.
[3]. J. J. M. Vreede-Swagemakers A. P. M. Gorgels W. I. Dubois-Arbouw et al.1997 Out-of-Hospital Cardiac Arrest in the 1990s: A population-based study in the Maastricht area on incidence, characteristics and survival J. Am. Coll. Cardiol. 30 1500–1505.
[4]. COMMIT 2005 Early intravenous than oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 1622–1632.
[5]. A. Jánosi J. K. Ghali J. Herlitz et al.2003 Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF Am. Heart J. 146 721–728.
[6]. S. H. Hohnloser K. H. Kuck P. Dorian et al.2004 DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N. Engl. J. Med. 351 2481–2488.
[7]. G. H. Bardy K. L. Lee D. B. Mark et al.2008 Home use of automated external defibrillators for sudden cardiac arrest N. Engl. J. Med. 358 1793–1804.